NASDAQ · Medical - Diagnostics & Research

ILMN (ILMN) Stock

$213.25 +2.95% NASDAQ: ILMN Healthcare

Valuation

MetricValue
Price$213.25
Market Cap$32.26B
P/E Ratio41.56
P/B Ratio11.96
P/S Ratio7.57
EPS (TTM)$5.44
52-Week High$231.63
52-Week Low$88.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE31.08%
ROA12.41%
ROCE18.57%
Gross Margin68.29%
Operating Margin18.33%
Net Margin18.36%
Debt/Equity0.89
Current Ratio1.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.5B$4.6B$4.5B$4.4B$4.3B
Operating Profit$-123.0M$-4.2B$-1.1B$-833.0M$864.0M
Net Profit$762.0M$-4.4B$-1.2B$-1.2B$850.0M
EPS$5.05$-28.05$-7.35$-7.69$5.45
Op Margin-2.7%-91.2%-23.7%-19.1%19.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$15.2B$12.3B$10.1B$6.3B$6.6B
Total Liabilities$4.5B$5.7B$4.4B$3.9B$3.9B
Cash$1.2B$2.0B$1.0B$1.1B$1.4B
Borrowings$2.5B$3.6B$2.3B$2.6B$2.6B

Latest News

Element Biosciences Prevails in German Patent Case Against Illumina Business Wire · Jul 14, 2026 Alamar Hits A High Note On Alzheimer's Buzz Trefis · Jul 13, 2026 Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group GuruFocus.com · Jul 13, 2026 Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. Motley Fool · Jul 13, 2026 Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN Zacks · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$545.0M$392.0M$478.0M$837.0M$1.1B
Investing Cash Flow$-1.3B$-877.0M$-426.0M$-306.0M$-203.0M
Financing Cash Flow$-582.0M$-54.0M$-42.0M$-1.1B$-783.0M
Net Cash Flow$-578.0M$779.0M$-963.0M$79.0M$291.0M
Free Cash Flow$337.0M$106.0M$282.0M$709.0M$931.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.31
EV / EBITDA26.05
FCF Yield2.76%
Quick Ratio1.40
Interest Coverage12.56
Return 1Y107.21%
Return 3Y26.40%
Return 5Y-50.25%

Ownership

Insiders Held0.20%
Institutions Held106.37%
Institutions Float Held106.58%
Institutional HolderSharesReport Date
Blackrock Inc.19,023,5902026-03-31
Capital World Investors15,549,9602026-03-31
Vanguard Portfolio Management LLC6,823,6542026-03-31
Vanguard Capital Management LLC6,594,8362026-03-31
State Street Corporation6,429,3442026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DGX $240.80 +1.94% 21.70 $26.58B 1.68%
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
HOLXHologic, Inc. $76.01 +0.00% 31.28 $16.97B 0.00%
ICLR $159.84 -0.97% 11.92 $12.24B 0.00%
LH $331.66 +1.24% 24.43 $27.20B 1.12%

About ILMN

ILMN is led by CEO Jacob Thaysen, employs 8,970 people, headquartered in San Diego, US, publicly traded since 2000.

ILMN stock trades at $213.25 with a market capitalization of $32.26B. The stock is valued at a price-to-earnings (P/E) ratio of 41.56, price-to-book of 11.96, price-to-sales of 7.57. Over the past 52 weeks the stock has ranged between $88.00 and $231.63, and currently trades 7.9% below its 52-week high.

On profitability, ILMN generates a return on equity (ROE) of 31.08% — well above the market average, a sign of a high-quality business, return on capital employed of 18.57%, an operating margin of 18.33%, a net profit margin of 18.36%.

In its most recent fiscal year, ILMN reported annual revenue of $4.3B, net profit of $850.0M, revenue has compounded at 6.0% a year over the last five years, profit at 5.3% a year.

The balance sheet shows a debt-to-equity ratio of 0.89, a current ratio of 1.75, total assets of $6.6B, $1.4B in cash and equivalents.

ILMN has an average daily trading volume of 1,907,172 shares, a beta of 1.46 (more volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides